share_log

Stifel Maintains Buy on ALX Oncology Holdings, Lowers Price Target to $10

Benzinga ·  Nov 14, 2023 12:51

Stifel analyst Bradley Canino maintains ALX Oncology Holdings (NASDAQ:ALXO) with a Buy and lowers the price target from $11 to $10.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment